To sum up, herein, we uncovered that transfer of miR-181a–2–3p via MSC-derived EVs altered the NOX4/p38 MAPK expression by negatively regulating EGR1, all of which leads to the inhibition of OS in PD (Fig. 10). The gene discussed is NOX4; the disease is Parkinson disease.